コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 o breast PD were stronger with DBT than with digital mammography.
2 (r = -0.26), and homogeneity (r = -0.33) at digital mammography.
3 ongly correlated to breast PD in DBT than in digital mammography.
4 ormance improvements that are available with digital mammography.
5 er QALY gained for age- and density-targeted digital mammography.
6 ests potential for modest dose reductions in digital mammography.
7 ulated microcalcifications in a phantom with digital mammography.
8 and discrimination of simulated lesions for digital mammography.
9 te the conditions present in screen-film and digital mammography.
10 participants underwent both screen-film and digital mammography.
11 and interval cancers and for screen-film and digital mammography.
12 diation dose on breast density estimation in digital mammography.
13 annual magnetic resonance imaging (MRI) and digital mammography.
14 without tomosynthesis underwent conventional digital mammography.
15 ast MR imaging gave consent to undergo DE CE digital mammography.
16 imaging and higher than that of conventional digital mammography.
18 aminations, 1.3% at subsequent examinations; digital mammography: 4.4% at initial examinations, 2.1%
19 inations; detection rate per 1000 women with digital mammography: 6.8 at initial examinations, 6.1 at
20 nique consists of high-energy and low-energy digital mammography after administration of iodinated co
22 digital mammography and tomosynthesis versus digital mammography alone among U.S. women aged 50-74 ye
23 o $226 for combined examinations vs $139 for digital mammography alone) and if reported interpretive
28 were two false-positive findings with DE CE digital mammography and 13 false-positive findings with
29 n 19.8% of the women who underwent FS before digital mammography and 17.1% of those who underwent dig
30 performance benchmarks for modern screening digital mammography and assess performance trends over t
32 ) imaging with that of conventional imaging (digital mammography and breast ultrasonography) in the i
33 e current state of the art in technology for digital mammography and data from clinical trials that s
34 mammography to the current era of full-field digital mammography and digital breast tomosynthesis.
35 oft-copy display is likely to be useful with digital mammography and is unlikely to significantly cha
36 ly collected for women undergoing diagnostic digital mammography and linked with cancer diagnoses fro
40 ffectiveness of biennial screening with both digital mammography and tomosynthesis versus digital mam
41 ard full-field digital mammography, low-dose digital mammography, and digital breast tomosynthesis.
43 mmography, percentage of women screened with digital mammography, and percentage of mammography recal
45 f automated breast density measurements with digital mammography are not substantially affected by va
46 significantly better diagnostic accuracy of digital mammography, as compared with screen-film mammog
47 This study included 201 women who underwent digital mammography at seven U.S. and Canadian medical c
48 icant tendency toward film being better than digital mammography (AUCs, 0.88 vs 0.70; P = .0025).
49 film mammography is more favorable than for digital mammography because film has a lower false-posit
50 ), and positive predictive values (PPVs) for digital mammography before and after radiologist experie
51 When radiation effects were included, annual digital mammography beginning at age 30 years maximized
53 ncer detection rates to historic outcomes of digital mammography combined with DBT (referred to as di
54 ported improved breast cancer detection with digital mammography compared with film mammography in se
55 andular dose was 39% lower in s2D/DBT versus digital mammography/DBT (4.88 mGy vs 7.97 mGy, respectiv
56 in cancer detection rate for s2D/DBT versus digital mammography/DBT (5.03 of 1000 vs 5.45 of 1000, r
58 adiation dose for 15 571 women screened with digital mammography/DBT from October 1, 2011, to Februar
63 8 (baseline examinations were performed with digital mammography), DCIS detection rates were determin
64 ation-induced cancer per 100,000 women using digital mammography, depending on age and screening inte
67 adiation, including screen-film mammography, digital mammography, digital breast tomosynthesis, dedic
68 tal breast tomosynthesis (DBT) combined with digital mammography (DM) decreases false-positive examin
69 PAA-compliant retrospective review of 10 728 digital mammography (DM) examinations from September 1,
71 interval cancers differ for two-dimensional digital mammography (DM) versus digital breast tomosynth
72 to prospectively compare cancer detection of digital mammography (DM), whole-breast ultrasound (WBUS)
75 Data were included of the first round of digital mammography examinations, performed in 17 screen
76 tomosynthesis (DBT) with that of full-field digital mammography (FFDM) alone and FFDM combined with
77 dy consisted of current and prior full-field digital mammography (FFDM) images and DBT images that we
79 (39 and 78 microm) and a clinical full-field digital mammography (FFDM) system that yields a 100-micr
81 V2), and PPV of biopsies performed (PPV3) of digital mammography for six radiologists were compared b
82 years of age) and age- and density-targeted digital mammography (for women <50 years of age or women
83 mammography screening, which is age-targeted digital mammography (for women <50 years of age) and age
85 om 3665 examinations (1502 combined and 2163 digital mammography) from July 2012 to January 2013 were
88 hese findings suggest that dose reduction in digital mammography has a measurable but modest effect o
89 ed thirty-three cases were selected from the Digital Mammography Image Screening Trial screening stud
91 breast screening program, the performance of digital mammography in the detection of DCIS and invasiv
93 MY trial (A Comparison of Tomosynthesis with Digital Mammography in the UK National Health Service Br
96 ography was increased and the sensitivity of digital mammography in women with nondense breasts was d
97 es obtained with screen-film mammography and digital mammography, including radiologic and pathologic
98 nclusion Recall rate, CDR, PPV2, and PPV3 of digital mammography increased after radiologist experien
99 and 1.9 minutes +/- 0.6 (range, 1.1-3.0) for digital mammography; interpretation time with combined t
100 screening for breast cancer is similar, but digital mammography is more accurate in women under the
103 ose protocols, including standard full-field digital mammography, low-dose digital mammography, and d
104 iagnostic accuracy of each of the individual digital mammography machines versus screen-film mammogra
106 old RRs are higher for annual screening with digital mammography (median, 4.3 [range, 3.3 to 10]) and
108 A total of 454,850 examinations (n=281,187 digital mammography; n=173,663 digital mammography + tom
110 sts prospectively read images from screening digital mammography or screening combined tomosynthesis
113 of tomosynthesis implementation); period 2: digital mammography plus tomosynthesis examinations from
116 The odds of a cancer being more visible at digital mammography--rather than being equally visible a
117 d breast cancer incidence and mortality from digital mammography screening are affected by dose varia
118 that high overall cancer detection rates in digital mammography screening are related to high detect
122 Intervention: Annual, biennial, or triennial digital mammography screening from ages 50 to 74 years (
123 quent screening rounds of a population-based digital mammography screening program, to assess differe
126 , the cost-effectiveness of density-targeted digital mammography screening varied from a base-case es
129 -digital mammography screening; and targeted digital mammography screening, which is age-targeted dig
130 aths from cancer than either all-film or all-digital mammography screening, with cost-effectiveness e
135 ects, the breast model indicated that annual digital mammography starting at age 25 years maximized L
136 life-years gained as biennial screening with digital mammography starting at age 40 years for women w
137 for lesions imaged with the General Electric digital mammography system than for lesions imaged with
138 n = 14) intermittently for 3 days by using a digital mammography system; subsequently, the animals we
139 crylate were acquired with SF and full-field digital mammography systems at matched exposure conditio
143 to $33,000) per QALY gained for age-targeted digital mammography to $84,500 (CI, $75,000 to $93,000)
145 ns (n=281,187 digital mammography; n=173,663 digital mammography + tomosynthesis) were evaluated.
147 ital mammography vs 91 (95% CI, 73-108) with digital mammography + tomosynthesis; difference, -16 (95
148 al mammography vs 5.4 (95% CI, 4.9-6.0) with digital mammography + tomosynthesis; difference, 1.2 (95
149 al mammography vs 4.1 (95% CI, 3.7-4.5) with digital mammography + tomosynthesis; difference, 1.2 (95
150 mammography vs 19.3 (95% CI, 16.6-22.1) with digital mammography + tomosynthesis; difference, 1.3 (95
153 for biopsies, 18.1 (95% CI, 15.4-20.8) with digital mammography vs 19.3 (95% CI, 16.6-22.1) with dig
154 cancer detection, 2.9 (95% CI, 2.5-3.2) with digital mammography vs 4.1 (95% CI, 3.7-4.5) with digita
155 cancer detection, 4.2 (95% CI, 3.8-4.7) with digital mammography vs 5.4 (95% CI, 4.9-6.0) with digita
156 : for recall rate, 107 (95% CI, 89-124) with digital mammography vs 91 (95% CI, 73-108) with digital
158 d in both a community setting, in which only digital mammography was available, and in two tertiary b
161 graphy comprised the only subgroup for which digital mammography was significantly better than film (
162 film-screen mammography, the sensitivity of digital mammography was significantly higher for women a
164 ennial screening program, the performance of digital mammography was studied in three screening regio
165 stic accuracy for combined tomosynthesis and digital mammography was superior to that of digital mamm
167 hed reader studies were performed to compare digital mammography with tomosynthesis against digital m
168 porary performance benchmarks for diagnostic digital mammography with use of recent data from the Bre
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。